What drugs target Rotavirus VP4 and VP7 surface proteins?

3+ drugs target Rotavirus VP4 and VP7 surface proteins, including RotaTeq, Rotateq vaccine, Rotarix (RV1).

What drug classes act on Rotavirus VP4 and VP7 surface proteins?

Drug classes acting on Rotavirus VP4 and VP7 surface proteins include Live attenuated vaccine.

3 drugs 3 marketed

All drugs that target Rotavirus VP4 and VP7 surface proteins — marketed and clinical-stage. Includes 1 drug classes acting on this target.

RotaTeq · National Institute of Pediatrics, Mexico · Live attenuated vaccine · Immunology / Infectious Disease
RotaTeq is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus.
Rotateq vaccine · University Hospital, Brest · Live attenuated vaccine · Immunology / Infectious Disease
RotaTeq is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.
Rotarix (RV1) · Telethon Kids Institute · Live attenuated vaccine · Immunology / Infectious Disease
Rotarix is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.